(Nasdaq: TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with central nervous system (CNS ... Nasdaq Delisting and Subsequent ...

Pacs Group said it is conducting an internal audit and cooperating with a government investigation into its referral and ...

Former President Donald Trump has boasted in recent months about “Right To Try,” a law he signed in 2018. It’s aimed at ...